Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0000950170-25-035490

SVP, Head of Finance & Admin. sold 917 shares at $11.83 ($10,848)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Scalzo Richard William SVP, Head of Finance & Admin. 2025-03-05 Sale 10b5-1 −917 $11.83 $10,848 123,673 D
Open-market sales · 917 sh · avg $11.83 · $10,848
Loading xslF345X05/ownership.xml…